T cell apoptosis and reactive oxygen species

Journal of Clinical Investigation

Volumn 111, Issue 5, 2003, Pages 575-581

  Hildeman, David A ^a   Mitchell, Thomas ^b   Kappler, John ^c,d,e   Marrack, Philippa ^c,d,e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ADJUVANT; ANTIGEN; ANTIOXIDANT; CALCINEURIN; CASPASE; CATALASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FAS LIGAND; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONOMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE C; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; UNINDEXED DRUG;

APOPTOSIS; AUTOIMMUNITY; CELL CYCLE; HUMAN; KINETICS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; FAS LIGAND PROTEIN; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

EID: 0037371946     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318007     Document Type: Review

References (54)

1. Badovinac, V.P., Porter, B.B., and Harty, J.T. 2002. Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 3:619-626.
2. Masopust, D., Vezys, V., Marzo, A.L., and Lefrancois, L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2413-2417.
3. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T., and Jenkins, M.K. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 410:101-105.
4. Kawabi, Y., and Ochi, A. 1991. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 349:245-248.
5. Goldstone, S.D., and Hunt, NH. 1997. Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim. Acta. 1355:353-360.
6. Devadas, S., Zaritskaya, L., Rhee, S.G., Oberley, L., and Williams, M.S. 2002. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195:59-70.
7. Hildeman, D.A., et al. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity. 10:735-744.
8. Aulwurm, U.R., and Brand, K.A. 2000. Increased formation of reactive oxygen species due to glucose depletion in primary cultures of rat thymocytes inhibits proliferation. Eur. J. Biochem. 267:5693-5698.
9. Halliwell, B., and Gutteridge, J.M.C. 1985. Free radicals in biology and medicine. Oxford University Press. Oxford, United Kingdom. 189 pp.
10. Gerson, D.F., Kiefer, H., and Eufe, W. 1982. Intracellular pH of mitogen-stimulated lymphocytes. Science. 216:1009-1010.
11. Harris, S.G., and Phipps, R.P. 2001. The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur. J. Immunol. 31:1098-1105.
12. Huang, W.C., Chio, C.C., Chi, K.H., Wu, H.M., and Lin, W.W. 2002. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp. Cell Res. 277:192-200.
13. Cauley, L.S., Miller, E.E., Yen, M., and Swain, S.L. 2000. Supetantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J. Immunol. 165:6056-6066.
14. Gardner, P.R. 1997. Superoxide-driven aconitase Fe-S recycling. Biosci. Rep. 17:33-42.
15. Gardner, R., Salvador, A., and Moradas-Ferreira, P. 2002. Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production? A minimalist explanation. Free Radic. Biol. Med. 32:1351-1357.
16. Droge, W., Eck, H.P., Gmunder, H., and Mihm, S. 1991. Modulation of lymphocyte Functions and immune responses by cysteine and cysteine derivatives. Am. J. Med. 91(Suppl. 3C):140S-144S.
17. Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165:173-194.
18. Shi, Y.F., Sahai, B.M., and Green, D.R. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:625-626.
19. Van Parijs, L., Peterson, D.A., and Abbas, A.K. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and Foreign antigens. Immunity. 8:265-274.
20. Peter, M.E, and Krammer, P.H. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10:545-551.
21. Tucek-Szabo, C.L., Andjelic, S., Lacy, E., Elkon, K.B., and Nikolic-Zugic, J. 1996. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. J. Immunol. 156:192-200.
22. Tschopp, J., Irmler, M., and Thome, M. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552-558.
23. Refaeli, Y., Van Parijs, L., London, C.A., Tschopp, J., and Abbas, A.K. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8:615-623.
24. Yeh, J.H., Hsu, S.C., Han, S.H., and Lai, M.Z. 1998. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188:1795-1802.
25. Chen, W., et al. 2001. Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J. Exp. Med. 194:439-453.
26. Schlapbach, R., et al. 2000. TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur. J. Immunol. 30:3680-3688.
27. Ramsdell, F., et al. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545-1553.
28. Williamson, J.R. 1986. Role of inositol lipid breakdown in the generation of intracellular signals. State of the art lecture. Hypertension. 8:II140-II156.
29. Schieven, G.L., et al. 1994. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J. Biol. Chem. 269:20718-20726.
30. Rengarajan, J., et al. 2000. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity. 12:293-300.
31. Bauer, M.K., et al. 1998. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273:8048-8055.
32. Maccarone, M., Rosato, N., and Agro, A.F. 1995. Electroporation enhances cell membrane peroxidation and luminescence. Biochem. Biophys. Res. Commun. 206:238-245.
33. Hildeman, D.A., et al. 2002. Activated T cell death in vivo mediated by pro-apoptotic Bcl-2 family member Bim. Immunity. 16:759-767.
34. Gonzalo, J.A., et al. 1994. A single injection of staphylococcus aureus enterotoxin B reduces autoimmunity in MRL/pr mice. Clin. Immunol. Immunopathol. 71:176-182.
35. Hildeman, D.A., Zhu, Y., Mitchell, T., Kappler, J., and Marrack, P. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14:354-359.
36. Zajac, A.J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
37. Newton, K., and Strasser, A. 1998. The Bcl-2 Family and cell death regulation. Curr. Opin. Genet. Dev. 8:68-75.
38. Zong, W.X., Lindsten, T., Ross, A.J., MacGregor, G.R., and Thompson, C.B. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members Fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:1481-1486.
39. Martinou, J.C., and Green, D.R. 2001. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2:63-67.
40. Strasser, A., Harris, A.W., Huang, D.C., Krammet, P.H., and Cory, S. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14:6136-6147.
41. Akbar, A.N., et al. 1993. The significance of low bcl-2 expression by CD450 T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med. 178:427-438.
42. Mitchell, T.C., et al. 2001. Immunological adjuvants promote activaced T cell survival via induction of Bcl-3. Nat. Immunol. 2:397-402.
43. Bouillet, P., et al. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:922-926.
44. Watson, P.A., Nesterova, A., Burant, C.F., Klemm, DJ., and Reusch, J.E. 2001. Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J. Biol. Chem. 276:46142-46150.
45. Wilson, B.E., Mochon, E., and Boxer, L.M. 1996. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol. 16:5546-5556.
46. Freeland, K., Boxer, L.M., and Latchman, D.S. 2001. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res. Mol. Brain Res. 92:98-106.
47. Bureau, F., et al. 2002. Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood. 99:3683-3691.
48. Majumdar, S., Lamothe, B., and Aggarwal, B.B. 2002. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J. Immunol. 168:2644-2651.
49. Ginis, I., et al. 2000. Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol. Med. 6:1028-1041.
50. Hirota, K., et al. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U. S. A. 94:3633-3638.
51. Waris, G., Huh, K.W., and Siddiqui, A. 2001. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell. Biol. 21:7721-7730.
52. Qin, S., and Chock, P.B. 2001. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling. Biochemistry. 40:8085-8091.
53. Maxwell, J.R., Weinberg, A., Prell, R.A., and Vella, A.T. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-112.
54. Mitchell, T., Kappler, J., and Marrack, P. 1999. Bystander virus infection prolongs activated T cell survival. J. Immunol. 162:4527-4535.